Purdue Pharma faced significant legal consequences as it received a $5.5 billion sentencing for its role in the opioid crisis. The pharmaceutical company was found guilty of systematic deception involving regulatory authorities and engaging in unethical practices of incentivizing healthcare professionals to increase opioid prescriptions. This landmark judgment represents a critical milestone in holding pharmaceutical corporations accountable for their contribution to the widespread addiction epidemic affecting millions globally.

Summary auto-generated by AI from the original publisher's content. Editorial standards.